VTRNA2−1, which is not directly linked to AD, plays a role in PKR inhibition, influencing cellular stress responses, and its methylation variation can affect gene expression patterns relevant to neurodegenerative processes [43]. Here, EIF2AK2 is linked to Alzheimer disease.